Ticagrelor 90mg
Ticagrelor 90mg is a pharmaceutical drug with 20 clinical trials. Currently 1 active trials ongoing. Historical success rate of 93.3%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.3%
14 of 15 finished
6.7%
1 ended early
1
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Ticagrelor Monotherapy After Stenting
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
Clinical Trials (20)
Ticagrelor Monotherapy After Stenting
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
Chronic Kidney Disease (CKD) Platelet Study
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
Early Versus Late Loading of Ticagrelol in Patients With STEMI
LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)
A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20